Description

The Zollinger-Ellison syndrome describes a constellation of findings associated with excess secretion of gastrin by neuroendocrine cells located in the upper abdomen.


 

Cases may be familial or sporadic. Familial cases are usually associated with the multiple endocrine neoplasia (MEN-I) syndrome.

 

Clinical features:

(1) severe peptic ulcer disease with hypersecretion of gastric acid and parietal cell hyperplasia (may be absent in up to 25% of patients)

(2) neuroendocrine cell hypersecretion of gastrin

(3) diarrhea (due to excess acid reaching the small intestine; I bet the pH of the stool would be low)

 

Peptic ulcer disease:

(1) do not respond to normal therapy or recur

(2) may be multiple

(3) ulceration present in unusual sites such as distal duodenum and proximal jejunum

(4) may result in bleeding and/or perforation

(5) severe esophagitis may be present

 

Neuroendocrine cell hypersecretion:

(1) insulin cell tumor of pancreas, which are often malignant

(2) non-beta islet cell hyperplasia in pancreas

(3) neuroendocrine cell tumors in the duodenum, jejunum, stomach, and/or biliary tree

 

Laboratory features:

(1) fasting serum gastrin levels usually elevated (may be > 1,000 pg per mL)

(2) positive secretin test (increase in serum gastrin after injection of secretin)

(3) basal acid output often > 15 mmol/h with very low pH (a random gastric aspirate >= 2.5 in a patient not taking antisecretory medications excludes ZE syndrome according to Maton)

(4) ratio of basal to maximal acid secretion >= 0.6

 


To read more or access our algorithms and calculators, please log in or register.